These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease. Stav AL, Aarsland D, Johansen KK, Hessen E, Auning E, Fladby T. Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633 [Abstract] [Full Text] [Related]
28. Neural evidence for defective top-down control of visual processing in Parkinson's and Alzheimer's disease. Nemcova Elfmarkova N, Gajdos M, Rektorova I, Marecek R, Rapcsak SZ. Neuropsychologia; 2017 Nov; 106():236-244. PubMed ID: 28974380 [Abstract] [Full Text] [Related]
29. Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease. Biundo R, Weis L, Pilleri M, Facchini S, Formento-Dojot P, Vallelunga A, Antonini A. J Neural Transm (Vienna); 2013 Apr; 120(4):627-33. PubMed ID: 23483334 [Abstract] [Full Text] [Related]
30. Clock test deficits related to the global cognitive state in Alzheimer's and Parkinson's disease. Saur R, Maier C, Milian M, Riedel E, Berg D, Liepelt-Scarfone I, Leyhe T. Dement Geriatr Cogn Disord; 2012 Apr; 33(1):59-72. PubMed ID: 22415211 [Abstract] [Full Text] [Related]
31. Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment. Yatawara C, Lim L, Chander R, Zhou J, Kandiah N. J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1375-1383. PubMed ID: 28103200 [Abstract] [Full Text] [Related]
32. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Aarsland D, Brønnick K, Larsen JP, Tysnes OB, Alves G, Norwegian ParkWest Study Group. Neurology; 2009 Mar 31; 72(13):1121-6. PubMed ID: 19020293 [Abstract] [Full Text] [Related]
34. Prospective memory performance in individuals with Parkinson's disease who have mild cognitive impairment. Costa A, Peppe A, Zabberoni S, Serafini F, Barban F, Scalici F, Caltagirone C, Carlesimo GA. Neuropsychology; 2015 Sep 31; 29(5):782-91. PubMed ID: 25643211 [Abstract] [Full Text] [Related]
35. Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease. Chung SJ, Park YH, Yoo HS, Lee YH, Ye BS, Sohn YH, Lee JM, Lee PH. Neurobiol Aging; 2019 Jun 31; 78():168-177. PubMed ID: 30947112 [Abstract] [Full Text] [Related]
36. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease. Goldman JG, Holden S, Bernard B, Ouyang B, Goetz CG, Stebbins GT. Mov Disord; 2013 Dec 31; 28(14):1972-9. PubMed ID: 24123267 [Abstract] [Full Text] [Related]
37. REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson's Disease. Jozwiak N, Postuma RB, Montplaisir J, Latreille V, Panisset M, Chouinard S, Bourgouin PA, Gagnon JF. Sleep; 2017 Aug 01; 40(8):. PubMed ID: 28645156 [Abstract] [Full Text] [Related]
39. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment. Fernández de Bobadilla R, Pagonabarraga J, Martínez-Horta S, Pascual-Sedano B, Campolongo A, Kulisevsky J. Mov Disord; 2013 Sep 01; 28(10):1376-83. PubMed ID: 23873810 [Abstract] [Full Text] [Related]
40. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population? Federico A, Trentin M, Zanette G, Mapelli D, Picelli A, Smania N, Tinazzi M, Tamburin S. Neurol Sci; 2017 Aug 01; 38(8):1461-1468. PubMed ID: 28550344 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]